Insider Sale: Chemed director reports 150-share disposition at $463.39

Rhea-AI Filing Summary

Insider sale reported by a company director. The Form 4 shows Patrick P. Grace, a Chemed Corp (CHE) director, sold 150 shares on 09/09/2025 at $463.39 per share. After the sale he directly beneficially owns 3,397 shares. No derivative transactions were reported and the filing is by one reporting person.

Positive

• Timely disclosure of an insider transaction by a company director via Form 4
• Continued direct ownership after the sale: 3,397 shares remain beneficially owned

Negative

• Director disposed of shares: 150 shares sold on 09/09/2025 at $463.39 per share

Insights

Corporate Governance Expert

TL;DR: Routine director sale disclosed; filing shows continued direct ownership but reduces holdings modestly.

The Form 4 documents a single open-market sale of 150 shares by a director, reported as a direct disposition at $463.39 per share on 09/09/2025, leaving 3,397 shares beneficially owned. This is a standard Section 16 disclosure that supports transparency around insider trading activity. The filing does not indicate any derivatives, 10% ownership, or an instruction/10b5-1 plan box checked, and no amendments were noted. From a governance perspective, timely and complete reporting is the primary takeaway; the transaction itself appears routine based on the information provided.

Securities Analyst

TL;DR: Insider sale recorded; impact appears neutral given single small disposition and remaining direct stake.

The reported sale on 09/09/2025 is coded as an ordinary disposition (Code S) of 150 shares at $463.39, leaving the reporting person with 3,397 shares. No derivatives or additional transactions are listed. For investors monitoring insider activity, this entry provides a clear, single-data-point view of recent insider liquidity. The filing contains no information about the reason for the sale, planned future transactions, or any change in role or ownership percentage, so it does not by itself indicate material change to company fundamentals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GRACE PATRICK P

(Last) (First) (Middle)

71 EAST 77TH ST

4C/5C

(Street)

NEW YORK NY 10075

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	09/09/2025		S		150	D	$463.39	3,397	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Patrick P. Grace	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Chemed Corporation (CHE)?

Patrick P. Grace, identified as a director, is the reporting person who signed the Form 4 on 09/10/2025.

What transaction was reported on the Form 4 for CHE?

Sale of 150 shares on 09/09/2025 at a price of $463.39 per share (Transaction Code S).

How many shares does the reporting person own after the reported transaction?

The reporting person directly beneficially owns 3,397 shares following the sale.

Were any derivative securities reported in this Form 4 for CHE?

No derivative securities were reported in Table II; only a non-derivative sale is listed.

Was this Form 4 filed jointly or by one reporting person?

The form was filed by one reporting person (individual filing).